1. Amato MP, Portaccio E, Goretti B, Zipoli V, Iudice A, Della Pina D, et al. Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study. Mult Scler. 2010 Dec;16(12):1474–82.
2. Glanz BI, Healy BC, Hviid LE, Chitnis T, Weiner HL. Cognitive deterioration in patients with early multiple sclerosis: a 5-year study. J Neurol Neurosurg Psychiatry. 2012 Jan;83(1):38–43.
3. Honarmand K, Akbar N, Kou N, Feinstein A. Predicting employment status in multiple sclerosis patients: the utility of the MS functional composite. J Neurol. 2011 Feb;258(2):244–9.
4. Jensen H, Ravnborg M, Mamoei S, Dalgas U, Stenager E. Changes in cognition, arm function and lower body function after slow-release fampridine treatment. Mult Scler. 2014 Dec;20(14):1872–80.
5. Magnin E, Sagawa Y, Chamard L, Berger E, Moulin T, Decavel P. Verbal fluencies and fampridine treatment in multiple sclerosis. Eur Neurol. 2015;74(5–6):243–50.